These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Increased expression of regulatory T cells and down-regulatory molecules in lepromatous leprosy. Palermo ML; Pagliari C; Trindade MA; Yamashitafuji TM; Duarte AJ; Cacere CR; Benard G Am J Trop Med Hyg; 2012 May; 86(5):878-83. PubMed ID: 22556091 [TBL] [Abstract][Full Text] [Related]
10. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae. Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193 [TBL] [Abstract][Full Text] [Related]
11. Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens. Upadhyay R; Dua B; Sharma B; Natrajan M; Jain AK; Kithiganahalli Narayanaswamy B; Joshi B BMC Infect Dis; 2019 Jan; 19(1):52. PubMed ID: 30642265 [TBL] [Abstract][Full Text] [Related]
12. Mycobacterium leprae reactive T cell clones from lepromatous leprosy patients after prolonged dapsone chemotherapy. Gill HK; Ridley DS; Ganesan J; Mustafa AS; Rees RJ; Godal T Lepr Rev; 1990 Mar; 61(1):25-31. PubMed ID: 2181222 [TBL] [Abstract][Full Text] [Related]
13. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2. Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366 [TBL] [Abstract][Full Text] [Related]
14. T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients. Launois P; Huygen K; De Bruyn J; N'Diaye M; Diouf B; Sarthouj L; Grimaud J; Millan J Clin Exp Immunol; 1991 Nov; 86(2):286-90. PubMed ID: 1934596 [TBL] [Abstract][Full Text] [Related]
15. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction. Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031 [TBL] [Abstract][Full Text] [Related]
16. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders. Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920 [TBL] [Abstract][Full Text] [Related]
18. Serum Levels of Migration Inhibitory Factor (MIF) and Martinez-Guzman MA; Alvarado-Navarro A; Delgado-Rizo V; Garcia-Orozco A; Mayorga-Rodríguez JA; Pereira-Suarez AL; Fafutis-Morris M Front Immunol; 2018; 9():246. PubMed ID: 29487601 [TBL] [Abstract][Full Text] [Related]
19. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development. Sampaio LH; Stefani MM; Oliveira RM; Sousa AL; Ireton GC; Reed SG; Duthie MS BMC Infect Dis; 2011 Jan; 11():26. PubMed ID: 21269435 [TBL] [Abstract][Full Text] [Related]
20. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components. Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]